Review on prescription compatibility of shaoyao gancao decoction and reflection on pharmacokinetic compatibility mechanism of traditional chinese medicine prescription based on in vivo drug interaction of main efficacious components

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Bi, Xiaolin ^a,b,c   Gong, Meirong ^a   Di, Liuqing ^a,b,c  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Jiangsu Engineering Research Center for Efficient Delivery System of TCM   (China)

^c Nanjing Engineering Research Center for Industrialization of Chinese Medicine Pellets   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBIFLORIN; CHINESE DRUG; GLYCYRRHIZIC ACID; PAEONIFLORIN; SHAOYAO GANCAO DECOCTION; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; CHINESE MEDICINE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; GLYCYRRHIZA; HUMAN; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA PROTEIN BINDING; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84934970180     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/208129     Document Type: Review

References (45)

1. X.-J. Wang, N. Zhang, C.-K. Chang et al., "The research status and future development of formulae compatibility," World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica, vol. 8, no. 4, pp. 13-16, 2006.
2. C.-H. Wang and Z.-D. Min, "Chemical components and pharmacological research of shaoyao," Shizhen Guoyi Guoyao, vol. 10, no. 7, pp. 544-546, 1999.
3. M.-Z. Xiao and A.-P. Hu, "Research progress on pharmacological efects of licorice and its application on AIDS," Hubei Journal of Traditional Chinese Medicine, vol. 28, no. 12, p. 48, 2006.
4. Z.-W. Qiu, D.-D. Luo, J.-M. Ren et al., "Efect on paeoniforin content in the decoction of Shaoyao Gancao decoction in diferent component proportion," Shizhen Guoyi Guoyao, vol. 19, no. 6, pp. 1454-1455, 2008.
5. H.-G. Tan, Y.-Q. Liu, and W.-X. Feng, "Chemical components research of Shaoyao Gancao decoction," China Journal of Chinese Mamteria Medica, vol. 20, no. 9, p. 550, 1995.
6. L. Shen, Y. Feng, D. Xu et al., "Studies on changes of in vitro and in vivo material base of Shaoyao Gancao decoction based on HPLC-DAD-ESI-MS," China Journal of Chinese Mamteria Medica, vol. 35, no. 15, pp. 1947-1952, 2010.
7. M. Chen, "Studies on compatible rationality of Shaoyao Gancao Decoction by serum HPLC fngerprint," China Pharmacy, vol. 21, no. 15, pp. 1347-1350, 2010.
8. L. Shen, L. Zhang, Y. Feng, D. Xu, and X. Lin, "Study on fnger-prints correlated with pharmacodynamic of Paeonia laclifora and Glycyrrhiza uralensis efective compounds," China Journal of Chinese Mamteria Medica, vol. 33, no. 22, pp. 2658-2662, 2008.
9. X.-J. Xu and S.-R. Jin, "Teefects of the diferent compatibilities of Shaoyaogancaotang treating dysmenorrhea about endothelin and nitrogen of model rats uterus," Journal of Information on TCM, vol. 11, no. 11, pp. 973-974, 2004.
10. T.-S. Liu, X.-H. Zhao, J.-A. Duan et al., "Study on anti-infammatory and analgesic action of total glucosides from Shaoyao Gancao Decoction and its compound mechanism," Trational Chinese Drug Reasearch and Clinical Pharmacology, vol. 18, no. 6, pp. 427-430, 2007.
11. T. Liu, X. Zhao, J. Duan, L. Di, and Y. Huang, "Inhibition and compatibility of Shaoyao Gancao Decoction on phospholipase A2 by fuorescent liposome," Chinese Traditional and Herbal Drugs, vol. 39, no. 7, pp. 1000-1004, 2008.
12. Y. Gu, Y. Feng, and D.-S. Xu, "Correlation between drug efects and serum HPLC fngerprint of active compositions of Radix paeoniae alba and Radix et Rhizowa Glycyrrhizae," Chinese Traditional Patent Medicine, vol. 30, no. 1, pp. 6-10, 2008.
13. J. Zhang, C. Lv, H.-N. Wang, and Y. Cao, "Synergistic interaction between total glucosides and total favonoids on chronic constriction injury induced neuropathic pain in rats," Pharmaceutical Biology, vol. 51, no. 4, pp. 455-462, 2013.
14. W.-P. Wang, C.-J. Wang, S. Gu et al., "Pharmacokinetic study of herbaceous compatibility of Peony Liquorice Decoction," World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica, vol. 11, no. 3, pp. 382-386, 2009.
15. L. Shen, R.-W. Hu, X. Lin et al., "Pharmacokinetics of characteristic efective ingredients from individual and combination Shaoyao and Gancao treatement in rats using HPLC fnger-printing," European Journal of Drug Metabolism and Pharma-cokinetics, vol. 37, no. 2, pp. 133-140, 2012.
16. Q. Xiang, G. Cheng, and J.-M. Chen, "Pharmacokinetics and bioavailability of Paeonia and Glycyrrhizae Rad.decoction in rats," Chinese Pharmaceutical Journal, vol. 35, no. 9, pp. 615-618, 2000.
17. L. Shen, L. Zhang, Y. Feng et al., "Pharmacokinetics of Paeonia laclifora and Glycyrrhiza uralensis compound," Chinese Traditional Patent Medicine, vol. 31, no. 3, pp. 374-377, 2009.
18. R. Hu, L. Shen, Y. Feng et al., "Pharmacokinetics study on characteristic ingredients of diferent-dose herbs of Shaoyao-Gancao decoction," Acta Pharmacentica Sinica, vol. 46, no. 3, pp. 329-332, 2011.
19. C.-H. Xu, P. Wang, Y. Wang et al., "Pharmacokinetic comparisons of two diferent combinations of Shaoyao-Gancao Decoction in rats: competing mechanisms between paeoniforin and glycyrrhetinic acid," Journal of Ethnopharmacology, vol. 149, no. 2, pp. 443-452, 2013.
20. Y. Wang, C. Xu, P. Wang et al., "Pharmacokinetic comparisons of diferent combinations of Shaoyao-Gancao-Decoction in rats: simultaneous determination of ten active constituents by HPLC-MS/MS," Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 932, no. 1, pp. 76-87, 2013.
21. P. Gan, M. Zhong, X. Huang et al., "Pharmacokinetic comparisons of albiforin and paeoniforin afer oral administration of Shaoyao-Gancao-Tang and single herb Paeony decoction to rats," Planta Medica, vol. 78, no. 3, pp. 237-243, 2012.
22. N. Li, X. Chen, D. Han, X. Yu, and Y. Su, "Infuence of gly-cyrrhizin on paeoniforin pharmacokinetic fate in unrestrained conscious rats by intravenous administration," China Journal of Chinese Mamteria Medica, vol. 34, no. 13, pp. 1720-1723, 2009.
23. Y.-M. Sun, Y. Yang, D. Li, T. Pu, X. Xie, and Q. Wang, "Efect of paeoniforin on the pharmacokinetics of glycyrrhizic acid and glycyrrhetinic acid in rats," Chinese Pharmaceutical Journal, vol. 47, no. 8, pp. 599-603, 2012.
24. N. Li, X.-J. Chen, L. Wu, Y. Lu, Y. He, and Y.-M. Su, "Infuence of glycyrrhizin on intestinal absorption of paeoniforin by the everted rat gut sac model," Lishizhen Medicine and Meteria Medicine Research, vol. 19, no. 12, pp. 2908-2909, 2008.
25. R. Xin, Intestinal absorption properties of Zhishi-Shaoyao and Shaoyao-Gancao in Sini [M.S. thesis], Jiangsu University, 2010.
26. W. B. Shui, Q. He, Z. Ge, and Y. Cheng, "Studies on absorption of paeoniforin in rat small intestines by HPLC-MS," Chinese Pharmaceutical Journal, vol. 42, no. 14, pp. 1098-1101, 2007.
27. D. He, M. Yan, H. Li et al., "Efects of radix glycyrrhiza and its main components on the function and expression of P-glycoprotein in Caco-2 cells," Chinese Pharmaceutical Journal, vol. 45, no. 10, pp. 751-755, 2010.
28. Y.-W. Liu, M. Yan, H.-D. Li et al., "Study on the efect of gly-cyrrhizic acid on toxicokinetics for brucine and the mechanism study of detoxication," Chinese Journal of Hospital Pharmacy, vol. 32, no. 16, pp. 1239-1243, 2012.
29. T. Nabekura, T. Yamaki, K. Ueno, and S. Kitagawa, "Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals," Cancer Chemotherapy and Pharmacology, vol. 62, no. 5, pp. 867-873, 2008.
30. X.-Q. Wu, B. Chen, H.-C. Huang et al., "The mutual actions between efective components of Chinese medicine and the compatibility mechanism based on the intestinal barrier," Journal of New Chinese Medicine, vol. 42, no. 9, pp. 102-105, 2010.
31. J.-H. Tu, D.-H. Hu, L.-L. Dai et al., "Efect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with diferent CYP2C19 genotypes," Xenobiotica, vol. 40, no. 6, pp. 393-399, 2010.
32. W.-Y. Hu, Y.-W. Li, Y.-N. Hou et al., "The induction of liver microsomal cytochome P450 by Glycyrrhiza uralensis and gly-cyrrhizic acid in mice," Biomedical and Environmental Sciences, vol. 12, no. 1, pp. 10-14, 1999.
33. J. Tu, Y. J. He, Y. Chen et al., "Efect of glycyrrhizin on the activity of CYP3A enzyme in humans," European Journal of Clinical Pharmacology, vol. 66, no. 8, pp. 805-810, 2010.
34. M. Paolini, L. Pozzetti, A. Sapone, and G. Cantelli-Forti, "Efect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases," Life Sciences, vol. 62, no. 6, pp. 571-582, 1998.
35. J.-H. Tu, The infuence on CYP450 of glycyrrhizin and its mechanism [M.S. thesis], Zhongnan University, 2010.
36. S. Tsukamoto, M. Aburatani, T. Yoshida, Y. Yamashita, A. A. El-Beih, and T. Ohta, "CYP3A4 inhibitors isolated from licorice," Biological and Pharmaceutical Bulletin, vol. 28, no. 10, pp. 2000-2002, 2005.
37. A.-X. Wang, Studies on the efective components of Fufangfuling-tang and the pharmacologic activities of the major components [Ph.D. thesis], Dalian Medical University, 2010.
38. J. Yang, R.-X. Peng, R. Kong, and J.-P. Yu, "Efects of 18c-glycyrrhizic acid on rat liver cytochome P450 is enzymes and phase II transferase," Acta Pharmacologica Sinica, vol. 36, no. 5, pp. 321-324, 2001.
39. X.-X. Liu, Metabolism of Paeoniforin and Albiforin, Hebei Medical University, Shijiazhang, China, 2010.
40. W. Chen, S.-W. Fu, and X. He, "In vitro plasma protein binding of 18H-glycyrrhizin in human by GC," Strait Pharmaceutical Journal, vol. 17, no. 4, pp. 59-60, 2005.
41. L. Guo, L. Pan, and H. Zhu, "Characteristics of biopharmaceu-tics and signifcance of preparation in attendants of Chinese herbal extracts," Chinese Traditional and Herbal Drugs, vol. 38, no. 9, pp. 1281-1286, 2007.
42. D. K. Yu, "The contribution of P-glycoprotein to pharmacoki-netic drug-drug interactions," Journal of Clinical Pharmacology, vol. 39, no. 12, pp. 1203-1211, 1999.
43. G.-L. Yan and X. Wang, "A study of TCM formula compatibility in the context of drug metabolic enzyme and transport protein," World Science and Technology, vol. 10, no. 5, pp. 25-28, 2008.
44. Y. Tan, A. Wu, B. Tan et al., "Study on the interactions of berberine displace other drug from their plasma proteins binding sites," Chinese Pharmacological Bulletin, vol. 18, no. 5, pp. 576-578, 2002.
45. H.-P. Hao, C.-N. Zheng, and G.-J. Wang, "Toughts and experimental exploration on pharmacokinetic study of herbal medicines with multiple-components and targets," Acta Phar-maceutica Sinica, vol. 44, no. 3, pp. 270-275, 2009.